Navigation Links
ESF's EMRC strengthens training course on clinical trials management
Date:2/14/2008

Around 170 doctors, nurses and medical researchers from Europe and North America were given important insights into how to run successful clinical trials across national boundaries at a two-day training course in Croydon, UK.

The course, sponsored by the European Science Foundation as part of its Pan-European Clinical Trials (ECT) programme, heard expert speakers on all aspects of clinical trials with a specific focus on the Euramos trial into the rare bone cancer osteosarcoma.

Dr. Carole Moquin-Pattey, head of the European Medical Research Councils (EMRC) unit from the ESF, said, It is crucial to have so many dedicated people sharing their expertise and experience. International collaboration on investigator-driven clinical trials is going to become increasingly important and workshops such as these are vital to help us improve and simplify the management of the many complex issues involved.

ESF is co-ordinating two clinical trials through its EUROCORES scheme. These trials are into two rare bone conditions, osteosarcoma (Euramos) and fibrous dysplasia (Profidys). International and European collaborations are vital for such rare conditions because no single country has sufficient patients to launch a study that would yield meaningful results.

Patients are currently being recruited to the studies and the meeting heard that recruitment is on target. The two ECT projects are proving crucial in laying the foundations for subsequent international trials: ESFs membership organisation for medical research councils across Europe, European Medical Research Councils (EMRC) recently announced a strategic review of cross-border trials, called a Forward Look, to pave the way for future investigator-driven clinical trials.

Topics discussed at the meeting in Croydon, on January 24 and 25, included tips on how best to present information to potential recruits to trials, regulations surrounding the reporting of adverse events affecting patients, how to ensure that the targeted number of patients are randomised in the trial in a timely manner, and key issues relating to the role of clinical pharmacists.


'/>"/>

Contact: Thomas Lau
tlau@esf.org
33-388-762-158
European Science Foundation
Source:Eurekalert

Related medicine news :

1. HEALTHeCAREERS Network Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
2. Heraeus Strengthens Medical Components Business
3. MedeFile Materially Strengthens Balance Sheet Through Equity Financing and Debt Conversion Totaling $4 Million
4. Dowden Custom Media Strengthens e-Media
5. Scientx USA Strengthens Leadership Team With Appointment of Bryce IntVeld as Vice President of Sales
6. Start Licensing, Inc. Further Strengthens Position in Cloning Industry With New Patents
7. Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
8. Pieris Strengthens its Management, as it Prepares for the Clinical Development of PRS-050, an Anticalin(R)-Based Novel Cancer Therapy
9. NIAID strengthens and expands Vaccine and Treatment Evaluation Units
10. Publicis Groupe Strengthens its Leadership in Digital and Integrated Healthcare Communications in Italy
11. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: